Ottawa – The future of cancer care in Canada is poised to undergo a remarkable transformation, driven by a surge of scientific advances and a renewed commitment to ensuring equitable access for all patients. As a global leader in oncology, Pfizer has been at the forefront of developing groundbreaking cancer therapies for over two decades. Nearly 40% of the company’s …